GE launches RCT alliance; Ventana unveils its iScan HT slide scanner prototype;

> GE has launched the Research Circle Technology to create an alliance between the company's scientists and leading universities worldwide. RCT will provide for easy access to GE's organic technology in an open innovation structure, according to a company release. GE statement

> Roche unit Ventana Medical Systems has unveiled its iScan HT slide scanner prototype at the 2011 College of American Pathologists annual meeting. The slide scanner holds up to 360 slides. "The VENTANA iScan HT slide scanner takes the speed of scanning and the image viewing experience to exceptional levels," explains Steve Burnell, lifecycle leader for advanced workflow. Ventana release

> AngioDynamics ($ANGO) has tapped Alan Panzer as senior VP and GM of the company's vascular unit. Panzer most recently served as president and CEO of DeVilbiss Healthcare. AngioDynamics release

> The FDA has granted 510(k) clearance to the new Fluke Biomedical ProSim vital signs simulators, which offer advanced technology for patient monitor testing. Fluke Biomedical release

> Moody's Investors Service has said it could downgrade a rating covering $650 million of PerkinElmer's ($PKI) debt after the company announced it was buying Caliper Life Sciences for $600 million. Story

And Finally... The Breathalyzer is known as a handheld device to determine one's blood alcohol level. However, it could have many diagnostic applications as well. Breathalyzers are able to measure these gases and compounds even in very low concentrations. In fact, one breath contains a lot of information about what's going on in our blood and in our bodies, helping doctors diagnose and monitor certain conditions. News

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.